Identification of Prognostic Gene Signatures by Developing a scRNA-Seq-Based Integration Approach to Predict Recurrence and Chemotherapy Benefit in Stage II–III Colorectal Cancer

Prospective identification of robust biomarkers related to prognosis and adjuvant chemotherapy has become a necessary and critical step to predict the benefits of adjuvant therapy for patients with stage II–III colorectal cancer (CRC) before clinical treatment. We proposed a single-cell-based progno...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zixuan, Xing, Kaiyuan, Zhang, Bo, Zhang, Yanru, Chai, Tengyue, Geng, Jingkai, Qin, Xuexue, Zhang, Xinxin, Xu, Chaohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604003/
https://www.ncbi.nlm.nih.gov/pubmed/36293319
http://dx.doi.org/10.3390/ijms232012460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604003/
https://www.ncbi.nlm.nih.gov/pubmed/36293319
http://dx.doi.org/10.3390/ijms232012460

Ejemplares similares